SELLAS Life Sciences Group Inc (NASDAQ:SLS)’s traded shares stood at 0.41 million during the latest session, with the company’s beta value hitting 2.16. At the last check today, the stock’s price was $1.52. The SLS share’s 52-week high remains $1.91, putting it -25.66% down since that peak but still an impressive 67.11% since price per share fell to its 52-week low of $0.50. The company has a valuation of $85.53M, with an average of 1.39 million shares over the past 3 months.

SELLAS Life Sciences Group Inc (NASDAQ:SLS) trade information

SELLAS Life Sciences Group Inc (SLS) has traded red over the past five days. The stock hit a weekly high of 1.5500. The 5-day price performance for the stock is 13.43%, and 46.15% over 30 days. With these gigs, the year-to-date price performance is 43.40%.

SELLAS Life Sciences Group Inc (SLS) estimates and forecasts

Looking at statistics comparing SELLAS Life Sciences Group Inc share performance against respective industry, we note that the company has outperformed competitors. SELLAS Life Sciences Group Inc (SLS) shares are 42.06% up over the last 6 months, with its year-to-date growth rate higher than industry average at 35.07% against 13.30%.

SLS Dividends

SELLAS Life Sciences Group Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. SELLAS Life Sciences Group Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.